AGA临床实践更新:血液检测在结直肠癌筛查中的当前作用述评
美国胃肠病学协会(AGA)发布的专家述评,回顾了结直肠癌血液筛查检测的现有证据,并利用已发表的模型研究分析了血液检测要达到与现有粪便检测和筛查结肠镜相当的效果所需的检测性能、间隔和 uptake。
要点
- 血液检测为结直肠癌筛查提供了新选择,但美国筛查依从性仍不理想且存在种族、民族和地理差异。
- AGA临床实践更新委员会委托并批准本述评,旨在为AGA会员提供及时指导。
- 述评利用已发表模型研究分析血液检测达到与粪便检测和结肠镜相当效果所需的性能特征、间隔和 uptake。
核心结论
- 本述评回顾了血液检测用于结直肠癌筛查的当前证据及其对筛查的潜在影响。
- 利用已发表模型研究分析了血液检测达到与现有粪便检测和筛查结肠镜相当效果所需的检测性能、间隔和 uptake。
研究设计与样本
- 美国胃肠病学协会(AGA)研究所临床实践更新委员会和AGA理事会委托并批准的专家述评。
- 稿件经临床实践更新委员会内部同行评审和《Clinical Gastroenterology and Hepatology》标准程序的外部同行评审。
主要发现
- 结直肠癌是美国发病和癌症相关死亡的主要原因之一。
- 尽管有多种筛查选择,美国结直肠癌筛查依从性仍不理想,且筛查率和结局存在种族、民族和地理差异。
- 诊断技术进步促进了结直肠癌筛查血液检测的开发和验证。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DESCRIPTION: Colorectal cancer (CRC) is a leading cause of morbidity and cancer-related mortality in the United States. Despite multiple screening options, adherence to CRC screening in the United States remains suboptimal, and there are racial, ethnic, and geographic disparities in CRC screening rates and outcomes. Advances in diagnostic technology have allowed for development and validation of blood tests for CRC screening. In this Clinical Practice Update, our aims were to review the current evidence on blood tests and the potential implications for CRC screening. We leveraged published modeling studies to understand the optimal test performance characteristics, interval, and uptake that would be needed for blood tests to achieve comparable effectiveness to that of currently available stool tests and screening colonoscopy. METHODS: This expert commentary was commissioned and approved by the American Gastroenterological Association (AGA) Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership. The manuscript underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Clinical Gastroenterology and Hepatology.
引用
- Shaukat A, Ladabaum U, Kanth P, et al. AGA Clinical Practice Update on Current Role of Blood Tests for Colorectal Cancer Screening: Commentary. Clin Gastroenterol Hepatol. 2025. PMID: 40267995. doi:10.1016/j.cgh.2025.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。